Does Prelude Therapeutics Inc (PRLD) Have What it Takes to be in Your Portfolio Friday?

A rating of 40 puts Prelude Therapeutics Inc (PRLD) near the middle of the Biotechnology industry according to InvestorsObserver. Prelude Therapeutics Inc's score of 40 means it scores higher than 40% of stocks in the industry. Prelude Therapeutics Inc also received an overall rating of 37, putting it above 37% of all stocks. Biotechnology is ranked 84 out of the 148 industries.

PRLD has an Overall Score of 37. Find out what this means to you and get the rest of the rankings on PRLD!

See Full PRLD Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 37 would rank higher than 37 percent of all stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Prelude Therapeutics Inc Stock Today?

Prelude Therapeutics Inc (PRLD) stock is down -8.08% while the S&P 500 is up 0.04% as of 9:50 AM on Friday, Oct 22. PRLD is down -$1.53 from the previous closing price of $18.93 on volume of 18,691 shares. Over the past year the S&P 500 has risen 31.79% while PRLD is down -41.26%. PRLD lost -$5.50 per share the over the last 12 months. Click Here to get the full Stock Report for Prelude Therapeutics Inc stock.